139 related articles for article (PubMed ID: 18695744)
1. HIV-1 capsid assembly inhibitor (CAI) peptide: structural preferences and delivery into human embryonic lung cells and lymphocytes.
Braun K; Frank M; Pipkorn R; Reed J; Spring H; Debus J; Didinger B; von der Lieth CW; Wiessler M; Waldeck W
Int J Med Sci; 2008 Jul; 5(5):230-9. PubMed ID: 18695744
[TBL] [Abstract][Full Text] [Related]
2. A cell-penetrating helical peptide as a potential HIV-1 inhibitor.
Zhang H; Zhao Q; Bhattacharya S; Waheed AA; Tong X; Hong A; Heck S; Curreli F; Goger M; Cowburn D; Freed EO; Debnath AK
J Mol Biol; 2008 May; 378(3):565-80. PubMed ID: 18374356
[TBL] [Abstract][Full Text] [Related]
3. Rationally designed interfacial peptides are efficient in vitro inhibitors of HIV-1 capsid assembly with antiviral activity.
Bocanegra R; Nevot M; Doménech R; López I; Abián O; Rodríguez-Huete A; Cavasotto CN; Velázquez-Campoy A; Gómez J; Martínez MÁ; Neira JL; Mateu MG
PLoS One; 2011; 6(9):e23877. PubMed ID: 21931621
[TBL] [Abstract][Full Text] [Related]
4. Heterologous expression, characterization and structural studies of a hydrophobic peptide from the HIV-1 p24 protein.
Castilho PV; Campana PT; Garcia AF; Beltramini LM; Araújo AP
Peptides; 2005 Feb; 26(2):243-9. PubMed ID: 15629535
[TBL] [Abstract][Full Text] [Related]
5. Antibody recognition of synthetic peptides mimicking immunodominant regions of HIV-1 p24 and p17 proteins.
Lottersberger J; Salvetti JL; Beltramini LM; Tonarelli G
Rev Argent Microbiol; 2004; 36(4):151-7. PubMed ID: 15786866
[TBL] [Abstract][Full Text] [Related]
6. Computational prediction of anti HIV-1 peptides and in vitro evaluation of anti HIV-1 activity of HIV-1 P24-derived peptides.
Poorinmohammad N; Mohabatkar H; Behbahani M; Biria D
J Pept Sci; 2015 Jan; 21(1):10-6. PubMed ID: 25407510
[TBL] [Abstract][Full Text] [Related]
7. Blocking of human immunodeficiency virus type-1 virion autolysis by autologous p2(gag) peptide.
Misumi S; Morikawa Y; Tomonaga M; Ohkuma K; Takamune N; Shoji S
J Biochem; 2004 Mar; 135(3):447-53. PubMed ID: 15113844
[TBL] [Abstract][Full Text] [Related]
8. Cellular translocation of a γ-AApeptide mimetic of Tat peptide.
Niu Y; Bai G; Wu H; Wang RE; Qiao Q; Padhee S; Buzzeo R; Cao C; Cai J
Mol Pharm; 2012 May; 9(5):1529-34. PubMed ID: 22413929
[TBL] [Abstract][Full Text] [Related]
9. Solution structure of a hydrocarbon stapled peptide inhibitor in complex with monomeric C-terminal domain of HIV-1 capsid.
Bhattacharya S; Zhang H; Debnath AK; Cowburn D
J Biol Chem; 2008 Jun; 283(24):16274-8. PubMed ID: 18417468
[TBL] [Abstract][Full Text] [Related]
10. Cooperative effects in phospholipid monolayers induced by a peptide from HIV-1 capsid protein.
Moraes ML; Bonardi C; Mendonça CR; Campana PT; Lottersberger J; Tonarelli G; Oliveira ON; Beltramini LM
Colloids Surf B Biointerfaces; 2005 Mar; 41(1):15-20. PubMed ID: 15698751
[TBL] [Abstract][Full Text] [Related]
11. Helical structure determined by NMR of the HIV-1 (345-392)Gag sequence, surrounding p2: implications for particle assembly and RNA packaging.
Morellet N; Druillennec S; Lenoir C; Bouaziz S; Roques BP
Protein Sci; 2005 Feb; 14(2):375-86. PubMed ID: 15659370
[TBL] [Abstract][Full Text] [Related]
12. The cationic cell-penetrating peptide CPP(TAT) derived from the HIV-1 protein TAT is rapidly transported into living fibroblasts: optical, biophysical, and metabolic evidence.
Ziegler A; Nervi P; Dürrenberger M; Seelig J
Biochemistry; 2005 Jan; 44(1):138-48. PubMed ID: 15628854
[TBL] [Abstract][Full Text] [Related]
13. The LLSGIV stretch of the N-terminal region of HIV-1 gp41 is critical for binding to a model peptide, T20.
Trivedi VD; Cheng SF; Wu CW; Karthikeyan R; Chen CJ; Chang DK
Protein Eng; 2003 Apr; 16(4):311-7. PubMed ID: 12736375
[TBL] [Abstract][Full Text] [Related]
14. Immunogenically optimized peptides derived from natural mutants of HIV CTL epitopes and peptide combinatorial libraries.
Blondelle SE; Moya-Castro R; Osawa K; Schroder K; Wilson DB
Biopolymers; 2008; 90(5):683-94. PubMed ID: 18481808
[TBL] [Abstract][Full Text] [Related]
15. Residues in the HIV-1 capsid assembly inhibitor binding site are essential for maintaining the assembly-competent quaternary structure of the capsid protein.
Bartonova V; Igonet S; Sticht J; Glass B; Habermann A; Vaney MC; Sehr P; Lewis J; Rey FA; Kraüsslich HG
J Biol Chem; 2008 Nov; 283(46):32024-33. PubMed ID: 18772135
[TBL] [Abstract][Full Text] [Related]
16. Allosteric Regulation of HIV-1 Capsid Structure for Gag Assembly, Virion Production, and Viral Infectivity by a Disordered Interdomain Linker.
Koma T; Kotani O; Miyakawa K; Ryo A; Yokoyama M; Doi N; Adachi A; Sato H; Nomaguchi M
J Virol; 2019 Sep; 93(17):. PubMed ID: 31189701
[TBL] [Abstract][Full Text] [Related]
17. Identification of a Structural Element in HIV-1 Gag Required for Virus Particle Assembly and Maturation.
Novikova M; Adams LJ; Fontana J; Gres AT; Balasubramaniam M; Winkler DC; Kudchodkar SB; Soheilian F; Sarafianos SG; Steven AC; Freed EO
mBio; 2018 Oct; 9(5):. PubMed ID: 30327442
[TBL] [Abstract][Full Text] [Related]
18. The Use of TAT Peptide-Functionalized Graphene as a Highly Nuclear-Targeting Carrier System for Suppression of Choroidal Melanoma.
Shan S; Jia S; Lawson T; Yan L; Lin M; Liu Y
Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31509978
[TBL] [Abstract][Full Text] [Related]
19. Anti-HIV-1 activity of anti-TAR polyamide nucleic acid conjugated with various membrane transducing peptides.
Tripathi S; Chaubey B; Ganguly S; Harris D; Casale RA; Pandey VN
Nucleic Acids Res; 2005; 33(13):4345-56. PubMed ID: 16077030
[TBL] [Abstract][Full Text] [Related]
20. A Cyclic Mimic of HIV Tat Differentiates Similar TAR RNAs on the Basis of Distinct Dynamic Behaviors.
Lu J; Nguyen L; Zhao L; Xia T; Qi X
Biochemistry; 2015 Jun; 54(23):3687-93. PubMed ID: 26016940
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
